News

PERNIX ESTABLISHES NEW CORPORATE HEADQUARTERS

MORRISTOWN, New Jersey, April 17, 2014 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced it has signed a lease for new corporate headquarters at 10 North Park Place in Morristown, NJ. The new headquarters will be occupied in mid-May and...
Read more

PERNIX AGREES TO DIVEST MANUFACTURING FACILITY

HOUSTON, Texas, April 1, 2014 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it has signed a definitive agreement to divest its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC (“PML”) to Woodfield Pharmaceutical LLC (“Woodfield”). Woodfield will acquire the...
Read more

PERNIX THERAPEUTICS APPOINTS SENIOR VICE PRESIDENT OF SALES AND MARKETING

HOUSTON, Texas, March 18, 2014 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced the appointment of Rick Shalaby as Senior Vice President of Sales and Marketing effective March 17, 2014. Mr. Shalaby brings over twenty-three years of successful industry experience,...
Read more